Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (IS) (2018 - 2025)

Orthofix Medical's Depreciation & Amortization (IS) history spans 7 years, with the latest figure at $12.9 million for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (IS) fell 14.71% year-over-year to $12.9 million, compared with a TTM value of $59.0 million through Sep 2025, up 33.53%, and an annual FY2023 reading of $53.1 million, up 82.86% over the prior year.
  • Depreciation & Amortization (IS) for Q3 2025 was $12.9 million at Orthofix Medical, down from $16.9 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $19.2 million in Q4 2021, with the low at $6.5 million in Q2 2022.
  • Average Depreciation & Amortization (IS) over 4 years is $10.8 million, with a median of $7.6 million recorded in 2021.
  • Year-over-year, Depreciation & Amortization (IS) skyrocketed 132.84% in 2021 and then tumbled 61.35% in 2022.
  • Tracing OFIX's Depreciation & Amortization (IS) over 4 years: stood at $19.2 million in 2021, then tumbled by 61.35% to $7.4 million in 2022, then skyrocketed by 104.46% to $15.2 million in 2024, then decreased by 14.71% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Depreciation & Amortization (IS) are $12.9 million (Q3 2025), $16.9 million (Q2 2025), and $15.2 million (Q3 2024).